Header cover image

Global Pharmaceuticals & Biotech Spotless Management

UPDATED Jul 03, 2022

Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.

3 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
603707Nanjing King-Friend Biochemical PharmaceuticalCN¥28.00-4.9%-10.5%CN¥34.7bCN¥31.67PE31.1xE26.6%0.5%
867China Medical System HoldingsHK$12.24-1.9%-38.7%HK$30.0bHK$16.89PE8.5xE8.0%4.7%
ROVILaboratorios Farmaceuticos Rovi€57.65-3.1%-2.1%€3.2b€76.77PE17.3xE10.3%1.7%
Page 1 of 1